{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:51:53Z","timestamp":1787791913872,"version":"build-2784847793"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015615","name":"NIDA CTN","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.josat.2023.209138","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T22:37:24Z","timestamp":1691188644000},"page":"209138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis"],"prefix":"10.1016","volume":"154","author":[{"given":"Dharushana","family":"Muthulingam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Hassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn M.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Bromberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liana","family":"Fraenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0005","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","article-title":"Opioid use fueling HIV transmission in an urban setting: An outbreak of HIV infection among people who inject drugs\u2014Massachusetts, 2015\u20132018","volume":"110","author":"Alpren","year":"2020","journal-title":"American Journal of Public Health"},{"issue":"8","key":"10.1016\/j.josat.2023.209138_bb0010","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/add.14946","article-title":"Acceptability and efficacy of naltrexone for criminal justice-involved individuals with opioid use disorder: A systematic review and meta-analysis","volume":"115","author":"Bahji","year":"2020","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.josat.2023.209138_bb0015","doi-asserted-by":"crossref","first-page":"e2023677","DOI":"10.1001\/jamanetworkopen.2020.23677","article-title":"Modeling mitigation strategies to reduce opioid-related morbidity and mortality in the US","volume":"3","author":"Ballreich","year":"2020","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1016\/j.josat.2023.209138_bb0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/cid\/ciaa062","article-title":"Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis","volume":"72","author":"Barocas","year":"2021","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.josat.2023.209138_bb0025","article-title":"Fatal re-entry: Legal and programmatic opportunities to curb opioid overdose among individuals newly released from incarceration","volume":"17","author":"Beletsky","year":"2015","journal-title":"School of Law Faculty Publications Paper"},{"key":"10.1016\/j.josat.2023.209138_bb0030","unstructured":"CDC, N. C. f. H. S., Office of Communication. (2021), November 17, 2021. Drug Overdose Deaths in the US Top 100,000 Annually https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20211117.htm."},{"issue":"1\u20133","key":"10.1016\/j.josat.2023.209138_bb0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drugalcdep.2007.11.003","article-title":"Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study","volume":"94","author":"Clausen","year":"2008","journal-title":"Drug and Alcohol Dependence"},{"issue":"10208","key":"10.1016\/j.josat.2023.209138_bb0040","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: Harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.josat.2023.209138_bb0045","article-title":"Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?","volume":"1-6","author":"Doernberg","year":"2019","journal-title":"Substance Abuse"},{"issue":"9596","key":"10.1016\/j.josat.2023.209138_bb0050","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE)statement: Guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.josat.2023.209138_bb0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pec.2010.04.034","article-title":"How to develop web-based decision support interventions for patients: A process map","volume":"82","author":"Elwyn","year":"2011","journal-title":"Patient Education and Counseling"},{"issue":"3","key":"10.1016\/j.josat.2023.209138_bb0060","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/humrep\/deq389","article-title":"Physicians underestimate the importance of patient-centredness to patients: A discrete choice experiment in fertility care","volume":"26","author":"van Empel","year":"2011","journal-title":"Human Reproduction"},{"key":"10.1016\/j.josat.2023.209138_bb0065","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1748-5908-8-56","article-title":"Exploring the feasibility of conjoint analysis as a tool for prioritizing innovations for implementation","volume":"8","author":"Farley","year":"2013","journal-title":"Implementation Science"},{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209138_bb0075","series-title":"The New York Times","article-title":"Seizing on opioid crisis, a drug maker lobbies hard for its product","author":"Goodnough","year":"2017"},{"issue":"3","key":"10.1016\/j.josat.2023.209138_bb0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"The American Journal on Addictions"},{"issue":"2","key":"10.1016\/j.josat.2023.209138_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J004v22n02_01","article-title":"Why addiction has a chronic, relapsing course. The neurobiology of addiction: Implications for occupational therapy practice","volume":"22","author":"Gutman","year":"2006","journal-title":"Occupational Therapy in Mental Health"},{"key":"10.1016\/j.josat.2023.209138_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108651","article-title":"Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective","volume":"221","author":"Hall","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209138_bb0095","series-title":"To Grow Market Sahre","author":"Harper","year":"2017"},{"key":"10.1016\/j.josat.2023.209138_bb0100","unstructured":"Health and Human Services. (2021), January 14. 2021. HHS Expands Access to Treatment for Opioid Use Disorder https:\/\/www.hhs.gov\/about\/news\/2021\/01\/14\/hhs-expands-access-to-treatment-for-opioid-use-disorder.html."},{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13011-016-0085-y","article-title":"Systemic and individual factors in the buprenorphine treatment-seeking process: A qualitative study","volume":"12","author":"Hewell","year":"2017","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"10.1016\/j.josat.2023.209138_bb0110","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bjid.2020.05.004","article-title":"Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil","volume":"24","author":"Hoagland","year":"2020","journal-title":"Brazilian Journal of Infectious Diseases"},{"issue":"10279","key":"10.1016\/j.josat.2023.209138_bb0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(21)00391-3","article-title":"The opioid crisis and HIV in the USA: Deadly synergies","volume":"397","author":"Hodder","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.josat.2023.209138_bb0120","doi-asserted-by":"crossref","unstructured":"Hyatt, J. M., & Lobmaier, P. P. (2020), 2020\/03\/14. Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: Balancing novel addiction treatments and voluntary participation. Health Justice, 8(1), 7. doi:https:\/\/doi.org\/10.1186\/s40352-020-0106-9.","DOI":"10.1186\/s40352-020-0106-9"},{"key":"10.1016\/j.josat.2023.209138_bb0125","series-title":"And care improvement: Workshop proceedings","article-title":"In partnering with patients to drive shared decisions, better value","author":"Institute of Medicine","year":"2014"},{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/0272989X16677031","article-title":"The influence of varying cost formats on preferences","volume":"37","author":"Jiang","year":"2017","journal-title":"Medical Decision Making"},{"issue":"5","key":"10.1016\/j.josat.2023.209138_bb0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/ADM.0000000000000166","article-title":"American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use","volume":"9","author":"Kampman","year":"2015","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"10.1016\/j.josat.2023.209138_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-054121","article-title":"PrEP distribution in pharmacies: A systematic review","volume":"12","author":"Kennedy","year":"2022","journal-title":"BMJ Open"},{"issue":"6","key":"10.1016\/j.josat.2023.209138_bb0150","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/L18-0685","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and mortality","volume":"170","author":"Larochelle","year":"2019","journal-title":"Annals of Internal Medicine"},{"issue":"10118","key":"10.1016\/j.josat.2023.209138_bb0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(17)32812-X","article-title":"Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): A multicentre, open-label, randomised controlled trial","volume":"391","author":"Lee","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08897077.2011.616797","article-title":"Opioid pharmacotherapy in criminal justice settings: Now is the time","volume":"33","author":"Lee","year":"2012","journal-title":"Substance Abuse"},{"issue":"8","key":"10.1016\/j.josat.2023.209138_bb0165","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/ciw416","article-title":"Impact of opioid substitution therapy on antiretroviral therapy outcomes: A systematic review and Meta-analysis","volume":"63","author":"Low","year":"2016","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.josat.2023.209138_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"Bmj"},{"key":"10.1016\/j.josat.2023.209138_bb0175","series-title":"The last shot","author":"MacGillis","year":"2017"},{"issue":"8","key":"10.1016\/j.josat.2023.209138_bb0180","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/add.14198","article-title":"An investigation of an open-access model for scaling up methadone maintenance treatment","volume":"113","author":"Madden","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209138_bb0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jsat.2018.01.003","article-title":"A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in Ukraine","volume":"86","author":"Marcus","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209138_bb0190","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000001827","article-title":"Opioid agonist treatment and improved outcomes at each stage of the HIV treatment Cascade in people who inject drugs in Ukraine","volume":"79","author":"Mazhnaya","year":"2018","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"10.1016\/j.josat.2023.209138_bb0195","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/1077558713496318","article-title":"Patient-centered approaches to health care: A systematic review of randomized controlled trials","volume":"70","author":"McMillan","year":"2013","journal-title":"Medical Care Research and Review"},{"key":"10.1016\/j.josat.2023.209138_bb0200","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2019.07.010","article-title":"Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?","volume":"105","author":"Meinhofer","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209138_bb0205","series-title":"Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support journal of substance Abuse treatment in press","author":"Muthulingam","year":"2019"},{"issue":"3","key":"10.1016\/j.josat.2023.209138_bb0210","article-title":"Survey of treatment preferences for opioid use disorder","volume":"5","author":"Nahata","year":"2018","journal-title":"Jacobs J Addict Ther"},{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12954-019-0296-4","article-title":"Prolonged-release opioid agonist therapy: Qualitative study exploring patients\u2019 views of 1-week, 1-month, and 6-month buprenorphine formulations","volume":"16","author":"Neale","year":"2019","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2023.209138_bb0220","first-page":"77","article-title":"Interpreting the results of conjoint analysis","volume":"2","author":"Orme","year":"2010","journal-title":"Getting Started with Conjoint Analyis: Strategies for Product Design and Pricing Research"},{"key":"10.1016\/j.josat.2023.209138_bb0225","series-title":"Sample size issues for conjoint analysis","author":"Orme","year":"2010"},{"issue":"11","key":"10.1016\/j.josat.2023.209138_bb0230","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.7326\/0003-4819-134-11-200106050-00020","article-title":"\u201cTell me about yourself\u201d: The patient-centered interview","volume":"134","author":"Platt","year":"2001","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.josat.2023.209138_bb0235","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-016-1375-0","article-title":"Attitudes toward addiction, methadone treatment, and recovery among HIV-infected Ukrainian prisoners who inject drugs: Incarceration effects and exploration of mediators","author":"Polonsky","year":"2016","journal-title":"AIDS and Behavior"},{"issue":"2","key":"10.1016\/j.josat.2023.209138_bb0240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1377\/hlthaff.2018.05232","article-title":"A transitioning epidemic: How the opioid crisis is driving the rise in hepatitis C","volume":"38","author":"Powell","year":"2019","journal-title":"Health Affairs"},{"issue":"9991","key":"10.1016\/j.josat.2023.209138_bb0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.josat.2023.209138_bb0145","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/ADM.0000000000000684","article-title":"Opioid use disorder and COVID-19: Crashing of the crises","volume":"14","author":"Khatri","year":"2020","journal-title":"J. Addict. Med."},{"issue":"4","key":"10.1016\/j.josat.2023.209138_bb0250","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11524-018-0256-4","article-title":"Perceptions of health-related community reentry challenges among incarcerated drug users in Azerbaijan, Kyrgyzstan, and Ukraine","volume":"95","author":"Rozanova","year":"2018","journal-title":"J. Urban Health: Bull. N. Y. Acad. Med."},{"issue":"14","key":"10.1016\/j.josat.2023.209138_bb0255","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jama.2015.10345","article-title":"Changes in substance Abuse treatment use among individuals with opioid use disorders in the United States, 2004-2013","volume":"314","author":"Saloner","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.josat.2023.209138_bb0260","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2020.01.009","article-title":"Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders","volume":"111","author":"Saunders","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209138_bb0265","author":"Sawtooth Software"},{"key":"10.1016\/j.josat.2023.209138_bb0270","author":"Sawtooth Software"},{"key":"10.1016\/j.josat.2023.209138_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108176","article-title":"Signal of increased opioid overdose during COVID-19 from emergency medical services data","volume":"214","author":"Slavova","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209138_bb0280","article-title":"Association between availability of medications for opioid use disorder in specialty treatment and use of medications among patients: A state-level trends analysis","volume":"132","author":"Solomon","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209138_bb0285","first-page":"Cd001431","article-title":"Decision aids for people facing health treatment or screening decisions","volume":"4","author":"Stacey","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2023.209138_bb0290","article-title":"HIV testing preferences among long distance truck drivers in Kenya: A discrete choice experiment","volume":"1-9","author":"Strauss","year":"2017","journal-title":"AIDS Care"},{"issue":"3","key":"10.1016\/j.josat.2023.209138_bb0295","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pec.2008.11.015","article-title":"How does communication heal? Pathways linking clinician-patient communication to health outcomes","volume":"74","author":"Street","year":"2009","journal-title":"Patient Education and Counseling"},{"key":"10.1016\/j.josat.2023.209138_bb0300","unstructured":"Substance Abuse and Mental Health Services Administration. (2020). FAQs: Provision of methadone and buprenorphine for the treatment of Opioid Use Disorder in the COVID-19 emergency https:\/\/www.samhsa.gov\/sites\/default\/files\/faqs-for-oud-prescribing-and-dispensing.pdf."},{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227968","article-title":"Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health","volume":"15","author":"Sugarman","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0310","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: A systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0315","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1521-0391.2011.00186.x","article-title":"Compliance with buprenorphine medication-assisted treatment and relapse to opioid use","volume":"21","author":"Tkacz","year":"2012","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.josat.2023.209138_bb0320","series-title":"Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs and Health","year":"2016"},{"key":"10.1016\/j.josat.2023.209138_bb2023","series-title":"Information about Medication-Assisted Treatment (MAT)","year":"2023"},{"issue":"2","key":"10.1016\/j.josat.2023.209138_bb0325","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.pec.2012.11.016","article-title":"Combining deliberation and intuition in patient decision support","volume":"91","author":"de Vries","year":"2013","journal-title":"Patient Education and Counseling"},{"issue":"2","key":"10.1016\/j.josat.2023.209138_bb0330","doi-asserted-by":"crossref","first-page":"e1920622","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"issue":"9","key":"10.1016\/j.josat.2023.209138_bb0335","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.addbeh.2012.04.011","article-title":"Predictors of attrition with buprenorphine\/naloxone treatment in opioid dependent youth","volume":"37","author":"Warden","year":"2012","journal-title":"Addictive Behaviors"},{"issue":"1","key":"10.1016\/j.josat.2023.209138_bb0340","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1369-6513.2000.00076.x","article-title":"Clinical decision-making in the context of chronic illness","volume":"3","author":"Watt","year":"2000","journal-title":"Health Expectations"},{"issue":"2","key":"10.1016\/j.josat.2023.209138_bb0345","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1016\/S2214-109X(16)30303-5","article-title":"Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: A two-arm, prospective observational study","volume":"5","author":"Wegman","year":"2017","journal-title":"The Lancet Global Health"},{"key":"10.1016\/j.josat.2023.209138_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108355","article-title":"Extended release injectable naltrexone before vs. after release: A randomized trial of opioid addicted persons who are in prison","volume":"127","author":"Woody","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2023.209138_bb0355","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/cid\/ciz1061","article-title":"The changing epidemiology of candidemia in the United States: Injection drug use as an increasingly common risk factor\u2014Active surveillance in selected sites, United States, 2014\u20132017","volume":"71","author":"Zhang","year":"2020","journal-title":"Clinical Infectious Diseases"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T15:50:43Z","timestamp":1757433043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923001893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":72,"alternative-id":["S2949875923001893"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209138","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preferences in medications for patients seeking treatment for opioid use disorder: A conjoint analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209138"}}